This study is aimed at evaluating the frequency of <i>KRAS</i>-G12C and <i>PIK3CA</i>-Q546K in adenomas and CRC from MAP patients and to demonstrate their relevance to reclassify <i>MUTYH</i> VUS. The gene discussed is KRAS; the disease is adenoma.